Description
Tocerapet is a veterinary anticancer medication for dogs containing Toceranib Phosphate. It is an alternative to Palladia and contains the same active ingredient used in veterinary oncology for the treatment of mast cell tumors and other types of neoplasms.
Tocerapet belongs to the tyrosine kinase inhibitor class. It helps slow the growth of tumor cells and blocks the formation of new blood vessels that supply tumors with nutrients. The medication should be used under the supervision of a veterinarian as part of an individualized treatment plan.
Benefits
-
Contains Toceranib Phosphate.
-
Alternative to Palladia.
-
Used in veterinary oncology.
-
Convenient tablet form.
-
Suitable for long-term treatment as prescribed by a veterinarian.
Indications
Tocerapet may be prescribed by a veterinarian for:
-
Mast cell tumors (MCT);
-
Recurrent skin tumors;
-
Tumors involving regional lymph nodes;
-
Other oncological conditions as recommended by a veterinary oncologist.
Composition
Active ingredient:
-
Toceranib Phosphate — 10 mg or 50 mg per tablet.
Directions for Use
Administer orally as directed by a veterinarian. Dosage is determined individually based on the dog's body weight, diagnosis, and treatment protocol.
Regular veterinary monitoring is recommended during treatment.
Package Size
4 tablets per pack.
Important
For use in dogs only. Do not use without veterinary supervision. Keep out of reach of children and animals.
